Sponsor-A-Scientist program launched

The Sbarro Health Research Organization, a nonprofit center for cancer, cardiovascular and diabetes research located at Temple University in Philadelphia and the University of Siena, Italy, has launched Sponsor-A-Scientist program.

The fellowship, which can be named in honor of a relative or loved one, will support a year of study under the direction of Antonio Giordano, M.D., Ph.D., the Founder and President of SHRO, the Director of the Sbarro Institute for Cancer Research and Molecular Medicine, and the Director of the Center for Biotechnology in the College of Science & Technology at Temple University in Philadelphia, PA. Dr. Giordano is also a 'Chiara fama' professor at the University of Siena, in Siena, Italy.

Despite recent increases in the budgets of the National Institutes of Health, which funds much of the country's biomedical research, dollars to pay for expensive research remain hard to come by for graduate and post-graduate students. Sponsor-A-Scientist's goal is to bring attention to and support for the work of young and gifted researchers, while giving the public an opportunity to be more directly involved in new and exciting medical discoveries.

"SHRO is at the forefront of molecular genetic discoveries in cancer and cardiovascular disease and in innovative methods to fund our important research," says Giordano. "This new initiative is an extension of our drive to support talented researchers and to uncover new resources to continue our work."

Source: http://www.newswise.com

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New therapy from UI Health becomes the first FDA-approved treatment for brittle type 1 diabetes